nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—Multiple fractures—Octreotide—thymus cancer	0.0457	0.0457	CcSEcCtD
Letrozole—Fracture—Octreotide—thymus cancer	0.0457	0.0457	CcSEcCtD
Letrozole—Neoplasm malignant—Octreotide—thymus cancer	0.0311	0.0311	CcSEcCtD
Letrozole—Breast pain—Octreotide—thymus cancer	0.0304	0.0304	CcSEcCtD
Letrozole—Viral infection—Octreotide—thymus cancer	0.0294	0.0294	CcSEcCtD
Letrozole—Phlebitis—Octreotide—thymus cancer	0.0224	0.0224	CcSEcCtD
Letrozole—Thrombophlebitis—Octreotide—thymus cancer	0.0223	0.0223	CcSEcCtD
Letrozole—Hot flush—Octreotide—thymus cancer	0.0206	0.0206	CcSEcCtD
Letrozole—Menopausal symptoms—Octreotide—thymus cancer	0.0204	0.0204	CcSEcCtD
Letrozole—Arthritis—Octreotide—thymus cancer	0.0198	0.0198	CcSEcCtD
Letrozole—Pain in extremity—Octreotide—thymus cancer	0.0193	0.0193	CcSEcCtD
Letrozole—Irritability—Octreotide—thymus cancer	0.0184	0.0184	CcSEcCtD
Letrozole—Dry skin—Octreotide—thymus cancer	0.0177	0.0177	CcSEcCtD
Letrozole—Influenza—Octreotide—thymus cancer	0.0167	0.0167	CcSEcCtD
Letrozole—Sweating increased—Octreotide—thymus cancer	0.0162	0.0162	CcSEcCtD
Letrozole—Pollakiuria—Octreotide—thymus cancer	0.0154	0.0154	CcSEcCtD
Letrozole—Weight increased—Octreotide—thymus cancer	0.0152	0.0152	CcSEcCtD
Letrozole—Weight decreased—Octreotide—thymus cancer	0.0151	0.0151	CcSEcCtD
Letrozole—Depression—Octreotide—thymus cancer	0.0148	0.0148	CcSEcCtD
Letrozole—Urinary tract infection—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Letrozole—Hepatobiliary disease—Octreotide—thymus cancer	0.014	0.014	CcSEcCtD
Letrozole—Hepatitis—Octreotide—thymus cancer	0.0133	0.0133	CcSEcCtD
Letrozole—Hypoaesthesia—Octreotide—thymus cancer	0.0133	0.0133	CcSEcCtD
Letrozole—Oedema peripheral—Octreotide—thymus cancer	0.0131	0.0131	CcSEcCtD
Letrozole—Cardiac disorder—Octreotide—thymus cancer	0.0124	0.0124	CcSEcCtD
Letrozole—Flushing—Octreotide—thymus cancer	0.0124	0.0124	CcSEcCtD
Letrozole—Alopecia—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Letrozole—Mental disorder—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Letrozole—Malnutrition—Octreotide—thymus cancer	0.0116	0.0116	CcSEcCtD
Letrozole—Tension—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Letrozole—Nervousness—Octreotide—thymus cancer	0.0113	0.0113	CcSEcCtD
Letrozole—Back pain—Octreotide—thymus cancer	0.0112	0.0112	CcSEcCtD
Letrozole—Vision blurred—Octreotide—thymus cancer	0.0109	0.0109	CcSEcCtD
Letrozole—Ill-defined disorder—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Letrozole—Malaise—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Letrozole—Vertigo—Octreotide—thymus cancer	0.0104	0.0104	CcSEcCtD
Letrozole—Palpitations—Octreotide—thymus cancer	0.0103	0.0103	CcSEcCtD
Letrozole—Cough—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Letrozole—Hypertension—Octreotide—thymus cancer	0.01	0.01	CcSEcCtD
Letrozole—Chest pain—Octreotide—thymus cancer	0.00988	0.00988	CcSEcCtD
Letrozole—Arthralgia—Octreotide—thymus cancer	0.00988	0.00988	CcSEcCtD
Letrozole—Myalgia—Octreotide—thymus cancer	0.00988	0.00988	CcSEcCtD
Letrozole—Anxiety—Octreotide—thymus cancer	0.00985	0.00985	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00981	0.00981	CcSEcCtD
Letrozole—Discomfort—Octreotide—thymus cancer	0.00976	0.00976	CcSEcCtD
Letrozole—Dry mouth—Octreotide—thymus cancer	0.00967	0.00967	CcSEcCtD
Letrozole—Anaphylactic shock—Octreotide—thymus cancer	0.00947	0.00947	CcSEcCtD
Letrozole—Oedema—Octreotide—thymus cancer	0.00947	0.00947	CcSEcCtD
Letrozole—Infection—Octreotide—thymus cancer	0.00941	0.00941	CcSEcCtD
Letrozole—Nervous system disorder—Octreotide—thymus cancer	0.00929	0.00929	CcSEcCtD
Letrozole—Tachycardia—Octreotide—thymus cancer	0.00925	0.00925	CcSEcCtD
Letrozole—Skin disorder—Octreotide—thymus cancer	0.0092	0.0092	CcSEcCtD
Letrozole—Hyperhidrosis—Octreotide—thymus cancer	0.00916	0.00916	CcSEcCtD
Letrozole—Anorexia—Octreotide—thymus cancer	0.00903	0.00903	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00863	0.00863	CcSEcCtD
Letrozole—Insomnia—Octreotide—thymus cancer	0.00857	0.00857	CcSEcCtD
Letrozole—Paraesthesia—Octreotide—thymus cancer	0.00851	0.00851	CcSEcCtD
Letrozole—Dyspnoea—Octreotide—thymus cancer	0.00845	0.00845	CcSEcCtD
Letrozole—Somnolence—Octreotide—thymus cancer	0.00842	0.00842	CcSEcCtD
Letrozole—Dyspepsia—Octreotide—thymus cancer	0.00834	0.00834	CcSEcCtD
Letrozole—Decreased appetite—Octreotide—thymus cancer	0.00824	0.00824	CcSEcCtD
Letrozole—Gastrointestinal disorder—Octreotide—thymus cancer	0.00818	0.00818	CcSEcCtD
Letrozole—Fatigue—Octreotide—thymus cancer	0.00817	0.00817	CcSEcCtD
Letrozole—Constipation—Octreotide—thymus cancer	0.0081	0.0081	CcSEcCtD
Letrozole—Pain—Octreotide—thymus cancer	0.0081	0.0081	CcSEcCtD
Letrozole—Feeling abnormal—Octreotide—thymus cancer	0.00781	0.00781	CcSEcCtD
Letrozole—Gastrointestinal pain—Octreotide—thymus cancer	0.00775	0.00775	CcSEcCtD
Letrozole—Urticaria—Octreotide—thymus cancer	0.00753	0.00753	CcSEcCtD
Letrozole—Abdominal pain—Octreotide—thymus cancer	0.00749	0.00749	CcSEcCtD
Letrozole—Body temperature increased—Octreotide—thymus cancer	0.00749	0.00749	CcSEcCtD
Letrozole—Asthenia—Octreotide—thymus cancer	0.0068	0.0068	CcSEcCtD
Letrozole—Pruritus—Octreotide—thymus cancer	0.0067	0.0067	CcSEcCtD
Letrozole—Diarrhoea—Octreotide—thymus cancer	0.00648	0.00648	CcSEcCtD
Letrozole—Dizziness—Octreotide—thymus cancer	0.00626	0.00626	CcSEcCtD
Letrozole—Vomiting—Octreotide—thymus cancer	0.00602	0.00602	CcSEcCtD
Letrozole—Rash—Octreotide—thymus cancer	0.00597	0.00597	CcSEcCtD
Letrozole—Dermatitis—Octreotide—thymus cancer	0.00597	0.00597	CcSEcCtD
Letrozole—Headache—Octreotide—thymus cancer	0.00594	0.00594	CcSEcCtD
Letrozole—Nausea—Octreotide—thymus cancer	0.00563	0.00563	CcSEcCtD
